Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Vaccines

Free Subscription 02.12.2024 1 Ann Intern Med 2 BMC Pediatr 1 BMJ 2 Clin Infect Dis 2 J Infect 4 J Infect Dis 1 N Engl J Med 1 Pediatrics 5 PLoS One 1 Proc Natl Acad Sci U S A 1 Science 20 Vaccine 2 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Intern Med

1. LAPRISE JF, Chesson HW, Markowitz LE, Drolet M, et al
   Cost-Effectiveness of Extending Human Papillomavirus Vaccination to Population Subgroups Older Than 26 Years Who Are at Higher Risk for Human Papillomavirus Infection in the United States.
   Ann Intern Med. 2024 Nov 26. doi: 10.7326/M24-0421.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

2. GENETI L, Shallo SA, Yebasa MA, Daba DB, et al
   Health workers' knowledge and practices toward vaccine cold chain management and its associated factors in a resource-limited setting of Sheger, Oromia, Ethiopia: a multicenter cross-sectional study.
   BMC Pediatr. 2024;24:786.
   PubMed         Abstract available
   
   
3. WOUDNEH AF, Shiferaw NT
   Exploring determinants of vaccination status among pediatric populations in East Gojam, Amhara Region, Ethiopia.
   BMC Pediatr. 2024;24:763.
   PubMed         Abstract available
   
   

   
   BMJ

4. MAJEED A
   Improving vaccine uptake during pregnancy.
   BMJ. 2024;387:q2631.
   PubMed        
   
   

   
   Clin Infect Dis

5. TOWNSEND JP, Hassler HB, Dornburg A
   Optimal Annual COVID-19 Vaccine Boosting Dates Following Previous Booster Vaccination or Breakthrough Infection.
   Clin Infect Dis. 2024 Nov 26:ciae559. doi: 10.1093.
   PubMed         Abstract available
   
   
6. CHOKEPHAIBULKIT K, Huoi C, Tantawichien T, Mootsikapun P, et al
   Non-inferiority study of purified Vero rabies vaccine - serum free in three-dose and two-dose pre-exposure prophylaxis regimens in comparison with licensed rabies vaccines.
   Clin Infect Dis. 2024 Nov 26:ciae581. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Infect

7. JIA T, Wang F, Chen Y, Liao G, et al
   Expanded immune imprinting and neutralization spectrum by hybrid immunization following breakthrough infections with SARS-CoV-2 variants after three-dose vaccination.
   J Infect. 2024 Nov 26:106362. doi: 10.1016/j.jinf.2024.106362.
   PubMed         Abstract available
   
   
8. CHOW KN, Tsang YW, Chan YH, Telaga SA, et al
   The effect of pre-COVID and post-COVID vaccination on long COVID: a systematic review and meta-analysis.
   J Infect. 2024 Nov 21:106358. doi: 10.1016/j.jinf.2024.106358.
   PubMed         Abstract available
   
   

   
   J Infect Dis

9. 
   Correction to: Half-life Estimation of Pertussis-Specific Maternal Antibodies in (Pre)Term Infants After In-Pregnancy Tetanus, Diphtheria, Acellular Pertussis Vaccination.
   J Infect Dis. 2024 Nov 25:jiae565. doi: 10.1093.
   PubMed        
   
   
10. 
    Expression of Concern: Relative Effectiveness and Waning of a Third Dose of mRNA COVID-19 Vaccine in Medicare Beneficiaries Aged 65 Years and Older during the BA.1/BA.2 Omicron Period.
    J Infect Dis. 2024 Nov 28:jiae549. doi: 10.1093.
    PubMed        
    
    
11. BURNETT E, Umana J, Anwari P, Mujuru HA, et al
    Rotavirus vaccine effectiveness stratified by national-level characteristics: an introduction to the 24-country MNSSTER-V Project, 2007-2023.
    J Infect Dis. 2024 Nov 28:jiae597. doi: 10.1093.
    PubMed         Abstract available
    
    
12. KANG HM, Kim HJ, Jung J, Ahn JY, et al
    Natural Boosting and the Immunogenicity of the XBB.1.5 Monovalent Vaccine in the Coronavirus Disease 2019 Endemic Era: A Longitudinal Observational Study.
    J Infect Dis. 2024 Nov 29:jiae536. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    N Engl J Med

13. YOSHIDA LM, Toizumi M, Nguyen HAT, Quilty BJ, et al
    Effect of a Reduced PCV10 Dose Schedule on Pneumococcal Carriage in Vietnam.
    N Engl J Med. 2024;391:1992-2002.
    PubMed         Abstract available
    
    

    
    Pediatrics

14. HUTTON DW, Prosser LA, Rose AM, Mercon K, et al
    Cost-Effectiveness of Maternal Vaccination to Prevent Respiratory Syncytial Virus Illness.
    Pediatrics. 2024 Nov 25:e2024066481. doi: 10.1542/peds.2024-066481.
    PubMed         Abstract available
    
    

    
    PLoS One

15. SITA L, Caserotti M, Zamparini M, Lotto L, et al
    Impact of COVID-19 vaccination on preventive behavior: The importance of confounder adjustment in observational studies.
    PLoS One. 2024;19:e0313117.
    PubMed         Abstract available
    
    
16. LAMICHHANE R, Adhikari P, Pathak BD, Rai A, et al
    Knowledge, attitude, and practice towards Hepatitis B and vaccination status of pre-clinical medical students at Sylhet Women's Medical College, Bangladesh.
    PLoS One. 2024;19:e0310443.
    PubMed         Abstract available
    
    
17. MARRA F, Yip M, Cragg JJ, Vadlamudi NK, et al
    Systematic review and meta-analysis of recombinant herpes zoster vaccine in immunocompromised populations.
    PLoS One. 2024;19:e0313889.
    PubMed         Abstract available
    
    
18. JUNGKUNZ S
    Asymmetric polarization by vaccination status identification during the COVID-19 pandemic.
    PLoS One. 2024;19:e0311962.
    PubMed         Abstract available
    
    
19. ANNI NS, Rehman N, Nyambi A, Musiwa A, et al
    Knowledge, attitudes, and practices towards Human Papilloma Virus and uptake of HPV vaccine: A protocol for a systematic review.
    PLoS One. 2024;19:e0313887.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

20. ABT ER, Lam AK, Noguchi M, Rashid K, et al
    Staggered immunization with mRNA vaccines encoding SARS-CoV-2 polymerase or spike antigens broadens the T cell epitope repertoire.
    Proc Natl Acad Sci U S A. 2024;121:e2406332121.
    PubMed         Abstract available
    
    

    
    Science

21. COHEN J
    Children are left behind in Congo's mpox vaccination drive.
    Science. 2024;386:954.
    PubMed         Abstract available
    
    

    
    Vaccine

22. WANG Q, Yang L, Li L, Xiu S, et al
    Investigating parental perceptions of respiratory syncytial virus (RSV) and attitudes to RSV vaccine in Jiangsu, China: Insights from a cross-section study.
    Vaccine. 2024;44:126570.
    PubMed         Abstract available
    
    
23. EDELSTEIN M, Shibli H, Bornstein J
    Differences in knowledge, attitudes and intentions towards HPV vaccination among young adults from diverse socio-cultural groups in Israel: A cross-sectional study.
    Vaccine. 2024;44:126548.
    PubMed         Abstract available
    
    
24. BORYS D, Smulders R, Haranaka M, Nakano T, et al
    Safety, reactogenicity, and immunogenicity of a novel 24-valent pneumococcal vaccine candidate in healthy, pneumococcal vaccine-naive Japanese adults: A phase 1 randomized dose-escalation trial.
    Vaccine. 2024;44:126545.
    PubMed         Abstract available
    
    
25. LINK EK, Tscherne A, Sutter G, Smith ER, et al
    A Brighton collaboration standardized template with key considerations for a benefit/risk assessment for a viral vector vaccine based on a non-replicating modified vaccinia virus Ankara viral vector.
    Vaccine. 2024;43.
    PubMed         Abstract available
    
    
26. PITTS PJ, Poland GA
    Addressing vaccine misinformation: The critical need for complete product information disclosure.
    Vaccine. 2024;44:126558.
    PubMed        
    
    
27. JONES-JACK N, El Kalach R, Yassanye D, Link-Gelles R, et al
    Advancing public health informatics during the COVID-19 pandemic: Lessons learned from a public-private partnership with pharmacies.
    Vaccine. 2024;42 Suppl 3:125667.
    PubMed         Abstract available
    
    
28. MEANEY-DELMAN D, Carroll S, Polen K, Jatlaoui TC, et al
    Planning for the future of maternal immunization: Building on lessons learned from the COVID-19 pandemic.
    Vaccine. 2024;42 Suppl 3.
    PubMed         Abstract available
    
    
29. COULTER FJ, Messer WB
    Breakthroughs and insights: A comprehensive review of yellow fever vaccine breakthrough infection across 8 decades.
    Vaccine. 2024;43.
    PubMed         Abstract available
    
    
30. TSAI Y, Leung J, Anderson TC, Zhou F, et al
    Herpes zoster vaccination among Medicare beneficiaries with and without prescription drug coverage.
    Vaccine. 2024;43.
    PubMed         Abstract available
    
    
31. REED NS, Brewer CC, Akintunde G, Blackie FF, et al
    Report of a SPEAC webinar 22 september 2023: Sensorineural hearing loss, lassa virus disease and vaccines.
    Vaccine. 2024;43.
    PubMed         Abstract available
    
    
32. GLESER D, Cohen M, Kenigswald G, Kedmi M, et al
    Optimizing protocols for the 919 strain-based bovine ephemeral fever virus vaccine (Ultravac(R), Zoetis): Evaluation of dose-dependent effectiveness and long-term immunity.
    Vaccine. 2024;43.
    PubMed         Abstract available
    
    
33. LEE M, Qin C, Lee Y, Deng J, et al
    COVID-19 vaccine acceptance and 5C psychological antecedents amid the omicron surge in South Korea and China.
    Vaccine. 2024;43.
    PubMed         Abstract available
    
    
34. CASTILLO-ZUNINO F, Hester KA, Keskinocak P, Nazzal D, et al
    Associations between family planning, healthcare access, and female education and vaccination among under-immunized children.
    Vaccine. 2024;44:126540.
    PubMed         Abstract available
    
    
35. DEAN NE, Halloran ME, Zarnitsyna VI
    Poor vaccine responders mask the true trend in vaccine effectiveness against progression to severe disease.
    Vaccine. 2024;43.
    PubMed         Abstract available
    
    
36. CHOI YJ, Jung J, Kang M, Choi MJ, et al
    The risk of pregnancy-related adverse outcomes after COVID-19 vaccination: Propensity score-matched analysis with influenza vaccination.
    Vaccine. 2024;44:126506.
    PubMed         Abstract available
    
    
37. YAMEY G, McDade KK, Anderson RM, Bartsch SM, et al
    Vaccine value profile for schistosomiasis.
    Vaccine. 2024 Jul 23:126020. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
38. AMODIO D, Angelidou A, Cotugno N, Sherman AC, et al
    Biomarkers of vaccine safety and efficacy in vulnerable populations: Lessons from the fourth international precision vaccines conference.
    Vaccine. 2024;43.
    PubMed         Abstract available
    
    
39. BLUKACZ A, Obach A, Vasquez P, Campana C, et al
    Determinants of COVID-19 and non-COVID-19 vaccine confidence in low- and middle-income countries: A systematic review of qualitative evidence and thematic synthesis.
    Vaccine. 2024;44:126546.
    PubMed         Abstract available
    
    
40. GEMANDER N, Kemlin D, Depickere S, Kelkar NS, et al
    COVID-19 vaccine responses are influenced by distinct risk factors in naive and SARS-CoV-2 experienced hemodialysis recipients.
    Vaccine. 2024;44:126544.
    PubMed         Abstract available
    
    
41. KASAIJA PD, Kabi F, Semakula J, Kyakuwa I, et al
    One-year follow-up evaluation of approved Subolesin anti-tick vaccine in Uganda.
    Vaccine. 2024;44:126562.
    PubMed         Abstract available
    
    

    
    Virology

42. ALI AA, Tabll AA
    Unlocking potential: Virus-like particles as a promising strategy for effective HCV vaccine development.
    Virology. 2024;602:110307.
    PubMed         Abstract available
    
    
43. JIN H, Zhao YR, Huang F, Hong Z, et al
    Vaccinia virus-mediated oncolytic immunotherapy: Emerging strategies for gastrointestinal cancer treatment at dawn.
    Virology. 2024;602:110303.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.